0
Other Articles |

RECENT DEVELOPMENTS IN THE TREATMENT OF UNDULANT FEVER

JAMA. 1938;111(19):1769. doi:10.1001/jama.1938.02790450051014.
Text Size: A A A
Published online

The increased recognition and incidence of undulant fever has fortunately been associated with new and improved methods of treating this disease, in both its acute and its chronic form. Vaccination has been employed for about ten years, in many instances with apparent success. Huddleson and Johnson1 have used a liver broth filtrate of the Brucella organism for intramuscular injection. This preparation is known as brucellin; the intramuscular injection of this filtrate has usually resulted in a local reaction and a rise in temperature. If precautions are taken to determine the sensitiveness of the patient before administration, these authors believe that it can be used without dangerous consequences. Foshay and his associates2 have employed detoxified bacterial antigens in the preparation of an antiserum for the treatment of undulant fever. Goats were used at first in the preparation of this antiserum but more recently horse serum has proved equally satisfactory.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs